US554306A
(en)
*
|
|
1896-02-11 |
|
Half to fred l |
US4444878A
(en)
|
1981-12-21 |
1984-04-24 |
Boston Biomedical Research Institute, Inc. |
Bispecific antibody determinants
|
US5292668A
(en)
|
1981-12-21 |
1994-03-08 |
Boston Biomedical Research Institute, Inc. |
Bispecific antibody determinants
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
US5869620A
(en)
|
1986-09-02 |
1999-02-09 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
FR2604092B1
(fr)
|
1986-09-19 |
1990-04-13 |
Immunotech Sa |
Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
|
US5766960A
(en)
|
1987-07-27 |
1998-06-16 |
Australian Membrane And Biotechnology Research Institute |
Receptor membranes
|
EP0382736B1
(de)
|
1987-07-27 |
1994-11-02 |
Commonwealth Scientific And Industrial Research Organisation |
Rezeptormembranen
|
US4943525A
(en)
|
1987-11-02 |
1990-07-24 |
Bioventures, Inc. |
Simultaneous immunoassay for the determination of antigens and antibodies
|
US4892824A
(en)
|
1988-03-15 |
1990-01-09 |
Synbiotics Corporation |
Fast track method for producing monoclonal bi-specific immunoglobulins
|
US6010902A
(en)
|
1988-04-04 |
2000-01-04 |
Bristol-Meyers Squibb Company |
Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
|
US5851527A
(en)
|
1988-04-18 |
1998-12-22 |
Immunomedics, Inc. |
Method for antibody targeting of therapeutic agents
|
US20030068322A1
(en)
|
1988-04-18 |
2003-04-10 |
Immunomedics, Inc. |
Methods of antibody-directed enzyme-prodrug therapy
|
JP2919890B2
(ja)
|
1988-11-11 |
1999-07-19 |
メディカル リサーチ カウンスル |
単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
US5980896A
(en)
|
1989-06-30 |
1999-11-09 |
Bristol-Myers Squibb Company |
Antibodies reactive with human carcinomas
|
IL94872A
(en)
|
1989-06-30 |
1995-03-30 |
Oncogen |
Monoclonal or chimeric antibodies that react with human carcinoma, recombinant proteins that contain their anti-binding site, pharmaceutical preparations and kits that contain the
|
US5332567A
(en)
|
1989-08-24 |
1994-07-26 |
Immunomedics |
Detection and treatment of infections with immunoconjugates
|
US5582996A
(en)
|
1990-12-04 |
1996-12-10 |
The Wistar Institute Of Anatomy & Biology |
Bifunctional antibodies and method of preparing same
|
CA2065658A1
(en)
|
1991-04-19 |
1992-10-20 |
Tse-Wen Chang |
Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
|
US5872222A
(en)
|
1991-04-19 |
1999-02-16 |
Tanox Biosystems, Inc. |
Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants
|
US6197298B1
(en)
|
1991-04-19 |
2001-03-06 |
Tanox, Inc. |
Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
|
US6129916A
(en)
|
1991-04-19 |
2000-10-10 |
Tanox, Inc. |
Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
|
US6106835A
(en)
|
1991-04-19 |
2000-08-22 |
Tanox, Inc. |
Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
|
DE4118120A1
(de)
|
1991-06-03 |
1992-12-10 |
Behringwerke Ag |
Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
|
US6887471B1
(en)
|
1991-06-27 |
2005-05-03 |
Bristol-Myers Squibb Company |
Method to inhibit T cell interactions with soluble B7
|
US5851795A
(en)
|
1991-06-27 |
1998-12-22 |
Bristol-Myers Squibb Company |
Soluble CTLA4 molecules and uses thereof
|
US5770197A
(en)
|
1991-06-27 |
1998-06-23 |
Bristol-Myers Squibb Company |
Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
|
US5844095A
(en)
|
1991-06-27 |
1998-12-01 |
Bristol-Myers Squibb Company |
CTLA4 Ig fusion proteins
|
US6090914A
(en)
|
1991-06-27 |
2000-07-18 |
Bristol-Myers Squibb Company |
CTLA4/CD28Ig hybrid fusion proteins and uses thereof
|
US5637481A
(en)
|
1993-02-01 |
1997-06-10 |
Bristol-Myers Squibb Company |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
|
EP0606217B2
(de)
|
1991-06-27 |
2008-12-03 |
Bristol-Myers Squibb Company |
CTL4A Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendungen
|
DE4134982A1
(de)
|
1991-10-23 |
1993-04-29 |
Kernforschungsz Karlsruhe |
Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression
|
US5932448A
(en)
|
1991-11-29 |
1999-08-03 |
Protein Design Labs., Inc. |
Bispecific antibody heterodimers
|
DE4140142A1
(de)
|
1991-12-05 |
1993-06-09 |
Boehringer Mannheim Gmbh, 6800 Mannheim, De |
Multivalentes dextranreagenz zum einsatz in praezipitationstests
|
CA2125396A1
(en)
|
1991-12-10 |
1993-06-24 |
Wayne A. Marasco |
Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
ATE295420T1
(de)
|
1992-02-06 |
2005-05-15 |
Chiron Corp |
Marker für krebs und biosynthetisches bindeprotein dafür
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
US6093399A
(en)
|
1992-03-05 |
2000-07-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the specific coagulation of vasculature
|
US5877289A
(en)
|
1992-03-05 |
1999-03-02 |
The Scripps Research Institute |
Tissue factor compositions and ligands for the specific coagulation of vasculature
|
DK0627940T3
(da)
|
1992-03-05 |
2003-09-01 |
Univ Texas |
Anvendelse af immunokonjugater til diagnose og/eller terapi af vaskulariserede tumorer
|
US6004555A
(en)
|
1992-03-05 |
1999-12-21 |
Board Of Regents, The University Of Texas System |
Methods for the specific coagulation of vasculature
|
US5776427A
(en)
|
1992-03-05 |
1998-07-07 |
Board Of Regents, The University Of Texas System |
Methods for targeting the vasculature of solid tumors
|
US6096289A
(en)
|
1992-05-06 |
2000-08-01 |
Immunomedics, Inc. |
Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy
|
EP1550729B1
(de)
|
1992-09-25 |
2009-05-27 |
Avipep Pty Limited |
Zielmoleküle-bindende Polypeptide bestehend aus einer IG-artigen VL Domäne die an eine IG-artige VH Domäne gebunden ist
|
WO1994008038A1
(en)
|
1992-10-02 |
1994-04-14 |
Trustees Of Dartmouth College |
Bispecific reagents for redirected targeting of low density lipoprotein
|
EP0627932B1
(de)
|
1992-11-04 |
2002-05-08 |
City Of Hope |
Antikörperkonstrukte
|
ES2276390T3
(es)
|
1992-11-05 |
2007-06-16 |
Sloan-Kettering Institute For Cancer Research |
Antigeno de membrana especifico de la prostata.
|
AU5670194A
(en)
|
1992-11-20 |
1994-06-22 |
Enzon, Inc. |
Linker for linked fusion polypeptides
|
US5376249A
(en)
|
1992-11-25 |
1994-12-27 |
Perseptive Biosystems, Inc. |
Analysis utilizing isoelectric focusing
|
EP0672142B1
(de)
|
1992-12-04 |
2001-02-28 |
Medical Research Council |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
GB9225453D0
(en)
|
1992-12-04 |
1993-01-27 |
Medical Res Council |
Binding proteins
|
EP0628078B1
(de)
|
1992-12-11 |
1999-12-08 |
The Dow Chemical Company |
Multivalente einkettige Antikörper
|
US5861156A
(en)
|
1993-01-08 |
1999-01-19 |
Creative Biomolecules |
Methods of delivering agents to target cells
|
US5773253A
(en)
|
1993-01-22 |
1998-06-30 |
Bristol-Myers Squibb Company |
MYPPPY variants of CTL A4 and uses thereof
|
US6482919B2
(en)
|
1993-02-01 |
2002-11-19 |
Bristol-Myers Squibb Company |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
|
DE69432744T2
(de)
|
1993-02-04 |
2004-03-25 |
Borean Pharma A/S |
Verbessertes verfahren zur rückfaltung der proteine
|
US5705614A
(en)
|
1993-04-09 |
1998-01-06 |
Chiron Corporation |
Methods of producing antigen forks
|
US5869049A
(en)
|
1993-09-02 |
1999-02-09 |
Trustees Of Dartmouth College |
Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists
|
NZ549136A
(en)
|
1993-09-02 |
2008-02-29 |
Dartmouth College |
Products for inducing antigen-specific T cell tolerance
|
ZA946765B
(en)
|
1993-09-02 |
1996-02-15 |
Dartmouth College |
Methods of prolonged suppression of humoral immunity
|
JPH09503759A
(ja)
|
1993-09-22 |
1997-04-15 |
メディカル リサーチ カウンシル |
抗体のリターゲッティング
|
GB9324807D0
(en)
|
1993-12-03 |
1994-01-19 |
Cancer Res Campaign Tech |
Tumour antibody
|
DE4421391C1
(de)
|
1994-06-18 |
1995-11-30 |
Gsf Forschungszentrum Umwelt |
Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression
|
US5965541A
(en)
|
1995-11-28 |
1999-10-12 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
US5559099A
(en)
|
1994-09-08 |
1996-09-24 |
Genvec, Inc. |
Penton base protein and methods of using same
|
US6465253B1
(en)
|
1994-09-08 |
2002-10-15 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
US5962311A
(en)
|
1994-09-08 |
1999-10-05 |
Genvec, Inc. |
Short-shafted adenoviral fiber and its use
|
US5541087A
(en)
|
1994-09-14 |
1996-07-30 |
Fuji Immunopharmaceuticals Corporation |
Expression and export technology of proteins as immunofusins
|
US5688690A
(en)
|
1994-09-16 |
1997-11-18 |
The Wistar Institute Of Anatomy And Biology |
Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto
|
DE69635801T2
(de)
|
1995-02-24 |
2006-11-02 |
Sloan-Kettering Institute For Cancer Research |
Prostataspezifisches membranes antigen und seine anwendungen
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
GB9504344D0
(en)
|
1995-03-03 |
1995-04-19 |
Unilever Plc |
Antibody fragment production
|
US5837281A
(en)
|
1995-03-17 |
1998-11-17 |
Takeda Chemical Industries, Ltd. |
Stabilized interface for iontophoresis
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
US5747035A
(en)
|
1995-04-14 |
1998-05-05 |
Genentech, Inc. |
Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
AUPO591797A0
(en)
|
1997-03-27 |
1997-04-24 |
Commonwealth Scientific And Industrial Research Organisation |
High avidity polyvalent and polyspecific reagents
|
US5830478A
(en)
|
1995-06-07 |
1998-11-03 |
Boston Biomedical Research Institute |
Method for delivering functional domains of diphtheria toxin to a cellular target
|
AU6873396A
(en)
|
1995-10-16 |
1997-05-07 |
Unilever N.V. |
A bifunctional or bivalent antibody fragment analogue
|
US5840854A
(en)
|
1995-10-19 |
1998-11-24 |
Bristol-Myers Squibb Company |
Monoclonal antibody BR110 and uses thereof
|
ES2260788T3
(es)
|
1996-03-25 |
2006-11-01 |
Medarex, Inc. |
Anticuerpos monoclonales especificos para el dominio estracelular de antigeno de membrana especifico de la prostata.
|
US6150508A
(en)
|
1996-03-25 |
2000-11-21 |
Northwest Biotherapeutics, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
US7381407B1
(en)
|
1996-03-25 |
2008-06-03 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
US6962981B1
(en)
|
1996-03-25 |
2005-11-08 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
EP0901630B1
(de)
|
1996-05-23 |
2003-08-20 |
Inverness Medical Switzerland GmbH |
Verbesserungen in oder in bezug auf spezifische bindungsassays
|
JP2000515735A
(ja)
|
1996-07-03 |
2000-11-28 |
ジェネンテック インコーポレーテッド |
肝細胞成長因子レセプターアゴニスト
|
GB9712818D0
(en)
|
1996-07-08 |
1997-08-20 |
Cambridge Antibody Tech |
Labelling and selection of specific binding molecules
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
US6653104B2
(en)
|
1996-10-17 |
2003-11-25 |
Immunomedics, Inc. |
Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
|
ES2191827T3
(es)
|
1996-10-17 |
2003-09-16 |
Immunomedics Inc |
Conjugado de toxina no antigenica y proteina de fusion de un sistema receptor de penetracion intracelular.
|
JP4663824B2
(ja)
|
1996-12-31 |
2011-04-06 |
ハイ スループット ジェノミクス インコーポレイテッド |
多重化分子分析装置および方法
|
US20080318254A9
(en)
|
1997-03-10 |
2008-12-25 |
The Regents Of The University Of California |
PSCA antibodies and hybridomas producing them
|
EP1514876B1
(de)
|
1997-03-10 |
2013-05-08 |
The Regents of The University of California |
Antikörper gegen das Prostata-Stammzellantigen (PSCA)
|
US6258939B1
(en)
|
1997-03-10 |
2001-07-10 |
The Regents Of The University Of California |
PSCA antibodies and hybridomas producing them
|
US6261789B1
(en)
|
1997-03-10 |
2001-07-17 |
The Regents Of The University Of California |
Methods for detecting the presence of a PSCA protein using PSCA antibodies
|
US6261791B1
(en)
|
1997-03-10 |
2001-07-17 |
The Regents Of The University Of California |
Method for diagnosing cancer using specific PSCA antibodies
|
US6541212B2
(en)
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
US6960443B2
(en)
|
1997-03-10 |
2005-11-01 |
The Regents Of The University Of California |
Methods of detecting prostate stem cell antigen in cancer
|
CA2286366C
(en)
|
1997-04-03 |
2008-10-07 |
Universite Laval |
Transgenic expression in genital tract and sexual accessory glands
|
WO1998050435A1
(en)
|
1997-05-02 |
1998-11-12 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Immunotoxins, comprising an onc protein, directed against malignant cells
|
US6368596B1
(en)
|
1997-07-08 |
2002-04-09 |
Board Of Regents, The University Of Texas System |
Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells
|
US6994851B1
(en)
|
1997-07-10 |
2006-02-07 |
Mannkind Corporation |
Method of inducing a CTL response
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
CA2302360C
(en)
|
1997-09-03 |
2005-11-15 |
Immunomedics, Inc. |
Fluorination of proteins and peptides for f-18 positron emission tomography
|
US6030792A
(en)
|
1997-11-13 |
2000-02-29 |
Pfizer Inc |
Assays for measurement of protein fragments in biological media
|
US6709844B1
(en)
|
2000-11-16 |
2004-03-23 |
Mannkind Corporation |
Avoidance of undesirable replication intermediates in plasmid propagation
|
DE19911329A1
(de)
|
1998-03-27 |
2000-09-21 |
Benes Ivan Friedrich |
Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung
|
HUP9900956A2
(hu)
|
1998-04-09 |
2002-04-29 |
Aventis Pharma Deutschland Gmbh. |
Egyláncú, több antigéntkötőhely kialakítására képes molekulák, előállításuk és alkalmazásuk
|
EP2261229A3
(de)
|
1998-04-20 |
2011-03-23 |
GlycArt Biotechnology AG |
Glykosylierungs-Engineering von Antikörpern zur Verbesserung der antikörperabhängigen zellvermittelten Zytotoxizität
|
US6200765B1
(en)
|
1998-05-04 |
2001-03-13 |
Pacific Northwest Cancer Foundation |
Non-invasive methods to detect prostate cancer
|
US6071490A
(en)
|
1998-05-07 |
2000-06-06 |
Immunomedics, Inc. |
Position emission tomography using gallium-68 chelates
|
CA2328528C
(en)
|
1998-05-20 |
2009-07-21 |
Immunomedics, Inc. |
Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
|
AU757698C
(en)
|
1998-06-01 |
2004-04-08 |
Agensys, Inc. |
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
AU750414B2
(en)
|
1998-07-13 |
2002-07-18 |
Board Of Regents, The University Of Texas System |
Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
|
AU5815699A
(en)
|
1998-09-08 |
2000-03-27 |
Urocor, Inc. |
Prostate specific promoter and regulation of gene expression
|
US6361774B1
(en)
|
1999-09-17 |
2002-03-26 |
Immunomedics, Inc. |
Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug
|
DE69928556T2
(de)
|
1998-09-29 |
2006-08-10 |
The Uab Research Foundation, Birmingham |
Immunmodulation mittels genetischer modifikation von dendritischen zellen und b-zellen
|
US6642007B1
(en)
|
1998-11-02 |
2003-11-04 |
Pfizer Inc. |
Assays for measurement of type II collagen fragments in urine
|
WO2000034461A2
(en)
|
1998-12-10 |
2000-06-15 |
Board Of Regents, The University Of Texas System |
Compositions and methods of modulating cholesterol metabolism
|
JP4540856B2
(ja)
|
1999-04-09 |
2010-09-08 |
ウニヴェルジテート・チューリッヒ |
キメラ免疫グロブリンまたは免疫グロブリン断片の新規安定化方法、および安定化された抗EGP−2scFv断片
|
AU775583B2
(en)
|
1999-04-13 |
2004-08-05 |
Medarex, Inc. |
Methods for the diagnosis and treatment of metastatic prostate tumors
|
US6703020B1
(en)
|
1999-04-28 |
2004-03-09 |
Board Of Regents, The University Of Texas System |
Antibody conjugate methods for selectively inhibiting VEGF
|
US6342221B1
(en)
|
1999-04-28 |
2002-01-29 |
Board Of Regents, The University Of Texas System |
Antibody conjugate compositions for selectively inhibiting VEGF
|
GB9915653D0
(en)
|
1999-07-06 |
1999-09-01 |
Bruce Terry |
Hose clamp
|
WO2001009303A2
(en)
|
1999-07-30 |
2001-02-08 |
Vical Inc. |
Flt-3 LIGAND-ENCODING POLYNUCLEOTIDE AS A POLYNUCLEOTIDE-BASED VACCINE ENHANCER
|
NZ523206A
(en)
|
1999-08-31 |
2004-12-24 |
Genentech Inc |
Antibodies that bind to tumor gene sequences
|
US6342587B1
(en)
|
1999-10-22 |
2002-01-29 |
Ludwig Institute For Cancer Research |
A33 antigen specific immunoglobulin products and uses thereof
|
US6346249B1
(en)
|
1999-10-22 |
2002-02-12 |
Ludwig Institute For Cancer Research |
Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products
|
US6824780B1
(en)
|
1999-10-29 |
2004-11-30 |
Genentech, Inc. |
Anti-tumor antibody compositions and methods of use
|
IL149116A0
(en)
*
|
1999-10-29 |
2002-11-10 |
Genentech Inc |
Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
|
PL358215A1
(en)
|
2000-03-24 |
2004-08-09 |
Micromet Ag |
Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
|
US6573096B1
(en)
|
2000-04-01 |
2003-06-03 |
The Research Foundation At State University Of New York |
Compositions and methods for inhibition of cancer invasion and angiogenesis
|
ES2637801T3
(es)
|
2000-04-11 |
2017-10-17 |
Genentech, Inc. |
Anticuerpos multivalentes y usos de los mismos
|
NZ521715A
(en)
|
2000-04-28 |
2008-01-31 |
Mannkind Corp |
Method of identifying and producing antigen peptides and use thereof as vaccines
|
US6861234B1
(en)
|
2000-04-28 |
2005-03-01 |
Mannkind Corporation |
Method of epitope discovery
|
US6375991B1
(en)
|
2000-09-08 |
2002-04-23 |
Albemarle Corporation |
Production of concentrated biocidal solutions
|
DE10045591A1
(de)
|
2000-09-15 |
2002-04-04 |
Klaus Pfizenmaier |
Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine)
|
WO2003008537A2
(en)
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
CN1555411A
(zh)
|
2001-08-03 |
2004-12-15 |
���迨�����\���ɷݹ�˾ |
抗体-依赖性细胞毒性增大的抗体糖基化变体
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
ES2537074T3
(es)
|
2001-09-06 |
2015-06-02 |
Agensys, Inc. |
Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
|
HUP0600342A3
(en)
|
2001-10-25 |
2011-03-28 |
Genentech Inc |
Glycoprotein compositions
|
EP1453471B1
(de)
|
2001-11-07 |
2011-01-05 |
Mannkind Corporation |
Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption
|
US20040018519A1
(en)
|
2001-11-16 |
2004-01-29 |
Wright ,Jr. George L |
Methods and devices for quantitative detection of prostate specific membrane antigen and other prostatic markers
|
US20050130899A1
(en)
|
2001-12-10 |
2005-06-16 |
Kyogo Itoh |
Tumor antigens
|
AU2002351353A1
(en)
|
2001-12-19 |
2003-09-02 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
JP4460302B2
(ja)
|
2002-02-05 |
2010-05-12 |
ジェネンテック インコーポレイテッド |
タンパク質精製法
|
WO2003102132A2
(en)
|
2002-04-26 |
2003-12-11 |
Genetech, Inc. |
Non-affinity purification of proteins
|
EP2365004B1
(de)
|
2002-06-21 |
2016-01-06 |
Johns Hopkins University School of Medicine |
Membranassoziierte Tumorendothel-Marker
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
US7820166B2
(en)
|
2002-10-11 |
2010-10-26 |
Micromet Ag |
Potent T cell modulating molecules
|
ATE475708T1
(de)
|
2003-01-22 |
2010-08-15 |
Glycart Biotechnology Ag |
Fusionskonstrukte und deren verwendung zur produktion von antikörpern mit erhöhter fc rezeptor bindungsaffinität und effektorfunktion
|
US20050026178A1
(en)
|
2003-03-28 |
2005-02-03 |
Marit Nilsen-Hamilton |
Allosteric probes and methods
|
GB0308988D0
(en)
|
2003-04-17 |
2003-05-28 |
Univ Singapore |
Molecule
|
NZ578591A
(en)
|
2003-05-30 |
2011-01-28 |
Agensys Inc |
Prostate stem cell antigen (PSCA) variants and subsequences thereof, namely SEQ ID NO: 6554
|
US7595379B2
(en)
|
2003-05-30 |
2009-09-29 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
US7541442B2
(en)
|
2003-05-30 |
2009-06-02 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
CA2523716C
(en)
|
2003-05-31 |
2014-11-25 |
Micromet Ag |
Human anti-human cd3 binding molecules
|
CA2529945A1
(en)
|
2003-06-27 |
2005-01-06 |
Biogen Idec Ma Inc. |
Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
|
EP3722309A1
(de)
|
2003-07-28 |
2020-10-14 |
Genentech, Inc. |
Verringerung des protein-a-auslaugens während einer affinitätschromatografie
|
GB0321805D0
(en)
|
2003-09-18 |
2003-10-15 |
Univ Wales Medicine |
Human tumour growth patterns
|
US7524813B2
(en)
|
2003-10-10 |
2009-04-28 |
Novo Nordisk Health Care Ag |
Selectively conjugated peptides and methods of making the same
|
EP1673398B1
(de)
|
2003-10-16 |
2010-12-29 |
Micromet AG |
Multispezifische deimmunisierte cd3-bindende moleküle
|
ES2428358T3
(es)
|
2003-10-17 |
2013-11-07 |
Novo Nordisk A/S |
Terapia de combinación
|
ITPD20030264A1
(it)
|
2003-10-30 |
2005-04-30 |
Xeptagen Spa |
Metodo di diagnosi altamente specifico per neoplasie
|
SG149815A1
(en)
|
2003-11-06 |
2009-02-27 |
Seattle Genetics Inc |
Monomethylvaline compounds capable of conjugation to ligands
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
EP1704228B1
(de)
|
2004-01-16 |
2012-04-11 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Immunokinasen
|
SI1716178T1
(sl)
|
2004-02-16 |
2010-11-30 |
Micromet Ag |
Manj imunogene vezne molekule
|
EP1718667B1
(de)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclische, selbst-immolative linker und konjugate
|
WO2005101017A1
(en)
|
2004-04-07 |
2005-10-27 |
Genentech, Inc. |
Mass spectrometry of antibody conjugates
|
WO2005106036A2
(en)
|
2004-04-12 |
2005-11-10 |
Medical College Of Ohio |
Methods and compositions for assaying analytes
|
CA2563735C
(en)
|
2004-04-22 |
2020-07-14 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to steap-1 proteins
|
MXPA06014065A
(es)
|
2004-06-01 |
2007-01-31 |
Genentech Inc |
Conjugados de droga-anticuerpo y metodos.
|
WO2005118802A2
(en)
|
2004-06-03 |
2005-12-15 |
The Regents Of The University Of California |
Targeting pseudotyped retroviral vectors
|
US20060159689A1
(en)
|
2004-06-17 |
2006-07-20 |
Chih-Sheng Chiang |
Combinations of tumor-associated antigens in diagnostics for various types of cancers
|
US20060008468A1
(en)
|
2004-06-17 |
2006-01-12 |
Chih-Sheng Chiang |
Combinations of tumor-associated antigens in diagnostics for various types of cancers
|
WO2006008096A1
(en)
|
2004-07-16 |
2006-01-26 |
Micromet Ag |
Expression-enhanced polypeptides
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
CN101065151B
(zh)
|
2004-09-23 |
2014-12-10 |
健泰科生物技术公司 |
半胱氨酸改造的抗体和偶联物
|
US20070134243A1
(en)
|
2004-12-01 |
2007-06-14 |
Gazzard Lewis J |
Antibody drug conjugates and methods
|
US7947839B2
(en)
|
2004-12-01 |
2011-05-24 |
Genentech, Inc. |
Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
|
CA2491067A1
(en)
|
2004-12-24 |
2006-06-24 |
Stichting Katholieke Universiteit |
Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
|
AU2006237616B9
(en)
|
2005-04-14 |
2012-12-06 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
CA2606018A1
(en)
|
2005-04-28 |
2006-11-02 |
Ventana Medical Systems, Inc. |
Nanoparticle conjugates
|
US8088908B2
(en)
|
2005-05-10 |
2012-01-03 |
City Of Hope |
Humanized anti-prostate stem cell antigen monoclonal antibody
|
GB2426581A
(en)
|
2005-05-27 |
2006-11-29 |
Univ Nottingham |
Immunoassay methods
|
SI2298815T1
(sl)
|
2005-07-25 |
2015-08-31 |
Emergent Product Development Seattle, Llc |
Zmanjšanje števila celic b z uporabo molekul, ki se specifično vežejo na cd37 in cd20
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
EP1942944A2
(de)
|
2005-10-31 |
2008-07-16 |
Genentech, Inc. |
Makrozyklische depsipeptid-antikörper-wirkstoff-konjugate und entsprechende verfahren
|
US20070212331A1
(en)
|
2006-03-07 |
2007-09-13 |
Baldassare Joseph J |
Methods and compositions for selectively killing cells
|
ES2363891T3
(es)
|
2006-03-20 |
2011-08-18 |
The Regents Of The University Of California |
Anticuerpos contra el antígeno de células troncales de la próstata (psca) modificados genéticamente para el direccionamiento al cáncer.
|
JP2009530423A
(ja)
|
2006-03-21 |
2009-08-27 |
ワイス |
アミロイド生成性疾患を予防および処置するための方法
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
US7566276B2
(en)
|
2006-04-14 |
2009-07-28 |
Dogleg Right Corporation |
Multi-piece putter head having an insert
|
US20110052697A1
(en)
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
US8574848B2
(en)
|
2006-09-13 |
2013-11-05 |
Oncimmune Ltd. |
Immunoassay methods
|
RU2450832C2
(ru)
|
2006-10-25 |
2012-05-20 |
Конинклейке Филипс Электроникс Н.В. |
Контрастные вещества для детекции рака предстательной железы
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
US8163886B2
(en)
|
2006-12-21 |
2012-04-24 |
Emd Millipore Corporation |
Purification of proteins
|
CA2682605A1
(en)
|
2007-04-18 |
2008-10-30 |
Zymogenetics, Inc. |
Single chain fc, methods of making and methods of treatment
|
EP2167537A2
(de)
|
2007-07-03 |
2010-03-31 |
Dako Denmark A/S |
Zusammengestellte verfahren für die analyse und sortierung von proben
|
US8940298B2
(en)
|
2007-09-04 |
2015-01-27 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
|
EP2197908A2
(de)
|
2007-09-27 |
2010-06-23 |
Dako Denmark A/S |
Mhc-multimere in tuberkulose-diagnostika, -impfstoff und therapeutika
|
RU2499606C2
(ru)
|
2007-10-18 |
2013-11-27 |
Бавэариан Нордик Инк. |
Применение mva (модифицированный вирус коровьей оспы анкара) для лечения рака простаты
|
US20090169613A1
(en)
|
2007-11-09 |
2009-07-02 |
Reznik Boris N |
Targeting of tumor stem cells through selective silencing of boris expression
|
US9107858B2
(en)
|
2007-12-05 |
2015-08-18 |
Wisconsin Alumni Research Foundation |
Dendritic cell targeting compositions and uses thereof
|
US8043830B2
(en)
|
2008-02-01 |
2011-10-25 |
The Regents Of The University Of California |
Biotin-ligase system for secretion of biotinylated protein
|
ES2547552T3
(es)
|
2008-02-01 |
2015-10-07 |
Genentech, Inc. |
Metabolito de nemorrubicina y reactivos análogos, conjugados anticuerpo-fármaco y métodos
|
TW200947474A
(en)
|
2008-05-05 |
2009-11-16 |
Ren-Huan Pan |
Manufacturing equipment and method of quadratic arc alignment dua-turret formation center, and miniature milliohm current sensors manufactured thereof
|
ES2544971T3
(es)
|
2008-05-13 |
2015-09-07 |
Genentech, Inc. |
Análisis de conjugados de fármacos y anticuerpos mediante espectrometría de masas con captura por afinidad basada en esferas
|
CA2727915C
(en)
|
2008-07-15 |
2016-04-26 |
Genentech, Inc. |
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
|
US20100069616A1
(en)
|
2008-08-06 |
2010-03-18 |
The Regents Of The University Of California |
Engineered antibody-nanoparticle conjugates
|
RU2509968C2
(ru)
|
2008-09-08 |
2014-03-20 |
Конокофиллипс Компани |
Система для отделения неконденсируемого компонента на установке для сжижения природного газа
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
WO2010037397A1
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cmv immune monitoring
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
MX338038B
(es)
|
2008-10-01 |
2016-03-30 |
Amgen Res Munich Gmbh |
Anticuerpo de una sola cadena bis-especifico de pscaxcd3, cd19xcd3, c-metxcd3, endosialinaxcd3, epcamxcd3, igf-1rxcd3 o fapalfaxcd3 de especies cruzadas.
|
US20110207155A1
(en)
|
2008-10-13 |
2011-08-25 |
Xeptagen Spa |
Method for the preparation of immunoconjugates and use thereof
|
US7897356B2
(en)
|
2008-11-12 |
2011-03-01 |
Caris Life Sciences |
Methods and systems of using exosomes for determining phenotypes
|
CN102308004A
(zh)
|
2008-10-30 |
2012-01-04 |
卡里斯生命科学卢森堡控股有限责任公司 |
评价rna图案的方法
|
CN102271708A
(zh)
|
2008-11-13 |
2011-12-07 |
新兴产品开发西雅图有限公司 |
Cd37免疫治疗联合疗法及其用途
|
SG171764A1
(en)
|
2008-12-16 |
2011-07-28 |
Millipore Corp |
Purification of proteins
|
CN102265059B
(zh)
|
2008-12-25 |
2013-08-07 |
东海橡塑工业株式会社 |
流体封入式隔振装置
|
JP5851842B2
(ja)
|
2009-01-12 |
2016-02-03 |
サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. |
改変した抗体組成物、それを作製および使用する方法
|
US20120004289A1
(en)
|
2009-03-06 |
2012-01-05 |
The Johns Hopkins University |
Annexin a11 and associated genes as biomarkers for cancer
|
CN110470835A
(zh)
|
2009-03-24 |
2019-11-19 |
生物概念股份有限公司 |
细胞捕获和分析的装置和方法
|
CN102459346B
(zh)
|
2009-04-27 |
2016-10-26 |
昂考梅德药品有限公司 |
制造异源多聚体分子的方法
|
US8680245B2
(en)
|
2009-05-28 |
2014-03-25 |
Glaxo Group Limited |
IL-13 binding protein
|
WO2011000054A1
(en)
|
2009-07-03 |
2011-01-06 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them
|
TWM383852U
(en)
|
2009-07-13 |
2010-07-01 |
Speedtech Corp |
An improvement of the universal serial bus connector
|
CN102573925B
(zh)
|
2009-10-05 |
2015-08-05 |
佳能株式会社 |
光声成像用造影剂和使用所述光声成像用造影剂的光声成像方法
|
EP3511023A1
(de)
|
2009-12-02 |
2019-07-17 |
Imaginab, Inc. |
J591-minikörper und cys-diakörper zur adressierung des prostataspezifischen membranantigens (psma) und verfahren zu deren verwendung
|
US20110142811A1
(en)
|
2009-12-16 |
2011-06-16 |
Deutsches Krebsforschungszentrum |
Measles virus for the elimination of unwanted cell populations
|
WO2011075786A1
(en)
|
2009-12-23 |
2011-06-30 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them 2
|
EP2519544A1
(de)
|
2009-12-29 |
2012-11-07 |
Emergent Product Development Seattle, LLC |
Polypeptidheterodimere und ihre verwendung
|
CN103237901B
(zh)
|
2010-03-01 |
2016-08-03 |
卡里斯生命科学瑞士控股有限责任公司 |
用于治疗诊断的生物标志物
|